Author: Megan Molteni

It’s how thousands of expectant parents see their baby’s face for the first time. And one day soon, it may be how doctors cure disease.

Blood tests can detect eight of the most common cancers—but their accuracy still isn’t high enough to be used clinically.

A growing set of direct-to-consumer genetic testing companies like BabyGlimpse are aimed at new, expecting, and aspiring parents. But beware their claims.

After 30 years in the making, gene therapy is finally an FDA-approved reality. What comes next—and how will Crispr get a slice of the action?

Bay Area residents were shaken awake by a 4.4 magnitude quake last night. But four people got warning notifications—and you could too.

Winter Storm Grayson isn't your typical bombogenerator, and more huge storms could follow.

AI could save medicine up to $100 billion a year, if we can only figure out how to apply it.

Crispr Classic can be clunky, unreliable, and a bit dangerous. But this year, newer, flashier gene editing tools began rolling off the production line.

A small group of scientists have dedicated their careers to unraveling the conifer's genetic secrets.

The best flu models still can't project the infection's trajectory more than a couple of weeks into the future. Here's how that could change.